Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons

Brain Research

Volumn 742, Issue 1-2, 1996, Pages 80-88

  Hall, Edward D ^a   Andrus, Paula K ^a   Oostveen, Jo A ^a   Althaus, John S ^a   Von Voigtlander, Philip F ^a  

^a PFIZER INC   (United States)

Author keywords

degeneration; ischemia; metham phetamine; neuroprotection; nigrostriatal; pramipexole

Indexed keywords

METHAMPHETAMINE; NEUROPROTECTIVE AGENT; PRAMIPEXOLE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; GERBIL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NERVE DEGENERATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANIMALS; BENZOTHIAZOLES; BRAIN ISCHEMIA; CORPUS STRIATUM; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GERBILLINAE; MALE; METHAMPHETAMINE; NERVE DEGENERATION; SUBSTANTIA NIGRA; THIAZOLES;

EID: 0030566729     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)00968-7     Document Type: Article

References (29)

1. 2 autoreceptor agonist, decreases the extracellular concentration of dopamine in vivo. Eur. J. Pharmacol. 200:1991;65-72.
2. Carvey P.M., Ptak L.R., Lo E.S., Lin D., Buhrgiend C.M., Goetz C.G., Klawans H.L. Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures. Exp. Neurol. 114:1991;28-34.
3. Cohen G. Monoamine oxidase, hydrogen peroxide and Parkinson's disease. Adv. Neurol. 45:1986;119-125.
4. Delbarre G., Delbarre B., Rochat C., Calinon F. Curative effect of piribedil, a D2 dopaminergic agonist, in gerbil cerebral ischemia. Soc. Neurosci. Abstr. 19:1993;1645.
5. Delbarre G., Delbarre B., Rochat C., Calinon F. Effect of piribedil, a D2 dopaminergic agonist, on dopamine, amino acids, free radicals in gerbil brain after cerebral ischemia. Soc. Neurosci. Abstr. 19:1993;637.
6. Felten D.F., Felten S.Y., Fuller R.W., Romano T.D., Smalstig E.B., Wong D.T., Clemens J.A. Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged Fischer-344 rats. Neurobiol. Aging. 13:1992;339-351.
7. Globus M.Y.T., Ginsberg M.D., Harik S.I., Busto R., Dietrich W.D. Role of dopamine in ischemic striatal injury. Neurology. 37:1987;1712-1719.
8. Globus M.Y.T., Ginsberg M.D., Dietrich W.D., Busto R., Scheinberg P. Substantial nigra lesion protects against ischemic damage in the striatum. Neurosci. Lett. 80:1987;251-256.
9. Hall E.D., Andrus P.K., Althaus J.S., VonVoigtlander P.F. Hydroxyl radical production and lipid peroxidation parallel selective post-ischemic vulnerability in gerbil brain. J. Neurosci. Res. 34:1993;107-112.
10. Hall E.D., Andrus P.K., Oostveen J.A., Althaus J.S., Fici G.J., VonVoigtlander P.F., Oien T.T., Sethy V.H. Post-ischemic degeneration of the nigrostriatal tract in gerbil brain: relationship to increased dopamine release and oxygen radical generation. J. Neurotrauma. 11:1994;111.
11. Hall E.D., Oostveen J.A., Dunn E.D., Carter D.B. Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils. Exp. Neurol. 135:1995;17-27.
12. Ishii H., Stanimirovic D.B., Chang C.J., Mrsulja B.B., Spatz M. Dopamine metabolism and free-radical related mitochondrial injury during transient brain ischemia in gerbils. Neurochem. Res. 18:1993;1193-1201.
13. Javoy-Agid, J., Dopaminergic cell death in Parkinson's disease. In L. Packer, L. Trilipko and Y. Christen (Eds.), Free Radicals in the Brain: Aging, Neurological and Mental Disorders, Springer-Verlag, New York, 1992, pp. 99-108.
14. Jenner P., Schapira A.H.V., Marsden C.D. New insights into the cause of Parkinson's disease. Neurology. 42:1992;2241-2250.
15. Lange, K.W., Rausch, W.-D., Gsell, W., Naumann, M., Oestreicher, E. and Riederer, P., Neuroprotection by dopamine agonists. J. Neural Transm., (Suppl.) 43 (1994) 183-201.
16. 2 receptor agonist. Eur. J. Pharmacol. 215:1992;161-170.
17. Ricaurte G.A., Guillery R.W., Seiden L.S., Schuster C.R., Moore R.Y. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 235:1982;93-103.
18. Saji M., Cohen M., Blau A.D., Wessel T.C., Volpe B.T. Transient forebrain ischemia induces delayed injury in the substantia niga reticulata: degeneration of GABA neurons, compensatory expression of GAD mRNA. Brain Res. 643:1994;234-244.
19. Shuaib A., Mazagri R., Ijaz S. GABA agonist muscimol is neuroprotective in repetitive transient forebrain ischemia in gerbils. Exp. Neurol. 123:1993;284-288.
20. Simonson S.G., Zhang J., Canada A.T., Su Y.-F., Benveniste H., Pantadiosi C.A. Hydrogen peroxide production by monoamine oxidase during ischemia-reperfusion in the rat brain. J. Cereb. Blood Flow Metab. 13:1993;125-134.
21. Sonsalla P.K., Jochnowitz N., Zeevalk G.D., German D.C. Nigral cell loss after methamphetamine treatment in mice. Soc. Neurosci. Abstr. 20:1994;175.
22. Spina M.B., Cohen G. Dopamine turnover and glutathione oxidation: implications for Parkinson's disease. Proc. Natl. Acad. Sci. USA. 86:1989;1398-1400.
23. Strasser A., Yasuma Y., McCarron R.M., Ishii H., Stanimirovic D., Spatz M. Effect of nitro-L-arginine on cerebral blood flow and monoamine metabolism during ischemia/reperfusion in the Mongolian gerbil. Brain Res. 664:1994;197-201.
24. 3 receptors. Eur. J. Pharmacol. 263:1994;235-243.
25. Tatton W.G., Greenwood C.E. Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism. J. Neurosci. Res. 30:1991;666-672.
26. Trulson M.E., Cannon M.S., Faegg T.S., Raese J.D. Effects of chronic methamphetamine on the nigral-striatal dopamine system in rat brain: tyrosine hydroxylase immunocytochemistry and quantitative light microscopic studies. Brain Res. Bull. 15:1985;569-577.
27. VonVoigtlander P.F., Burrian M.A., Althaus J.S., Williams L.R. Effects of chronic haloperidol or vitamin E levels and monoamine metabolism in rats fed normal and vitamin E deficient diets. Res. Commun. Chem. Pathol. Pharmacol. 68:1990;343-352.
28. Weinberger J., Cohen G. Nerve terminal damage in cerebral ischemia: greater susceptibility of catecholamine nerve terminals relative to serotonin nerve terminals. Stroke. 14:1983;986-989.
29. Youdim M.B.H., Ben-Schachar D., Reiderer P. The possible role of iron in the etiopathology of Parkinson's disease. Movement Disord. 8:1993;1-12.